ImmunosuppressantsVaricella zoster virus reactivation and its complications: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1544卷 / 1期

关键词：

D O I：

10.1007/s40278-015-8976-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：129 / 129

相关论文

共 50 条

[41] MethylprednisoloneVaricella zoster virus infection reactivation: case report
Reactions Weekly, 2024, 2032 (1) : 256 - 256
[42] TozinameranVaricella-zoster virus reactivation: case report
Reactions Weekly, 2022, 1887 (1) : 659 - 659
[43] OcrelizumabVaricella zoster virus reactivation encephalitis: case report
Reactions Weekly, 2021, 1875 (1) : 270 - 270
[44] RuxolitinibVaricella zoster virus clinical reactivation: case report
Reactions Weekly, 2020, 1787 (1) : 445 - 445
[45] AlemtuzumabVirus reactivation: 6 case reports
Reactions Weekly, 2015, 1547 (1) : 19 - 19
[46] ElotuzumabVaricella zoster reactivation, hepatitis B virus and acute hepatitis E infection: 3 case reports
Reactions Weekly, 2019, 1745 (1) : 118 - 118
[47] Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports
Triantafyllidis, Konstantinos Katsikas
Giannos, Panagiotis
Mian, Imran Tariq
Kyrtsonis, George
Kechagias, Konstantinos S.
VACCINES, 2021, 9 (09)
[48] Methotrexate/prednisolone/tocilizumabPrimary Varicella zoster virus infection: 6 case reports
Reactions Weekly, 2019, 1755 (1) : 218 - 218
[49] PrednisoloneCytomegalovirus reactivation and associated complications: 4 case reports
Reactions Weekly, 2018, 1689 (1) : 164 - 164
[50] ImmunosuppressantsVaricella zoster virus infection, Epstein Barr virus infection and thrombotic microangiopathy secondary to drug toxicity : case report
Reactions Weekly, 2021, 1854 (1) : 188 - 188

← 1 2 3 4 5 →